About Us / Contact Us
Technical Collaboration
If you are doing research in an area of diagnostic interest, MBS offers you the opportunity to develop and own a custom antibody for your research while generating income for your university or research institute.
Investigators and scientists who have interest in developing an antibody or own an antibody with diagnostic value should contact our Technical Marketing Specialist. Maine Biotechnology Services has over 18 years experience partnering with diagnostic and pharmaceutical companies in the area of custom hybridoma development and bulk antibody production. Our formula for a successful technical collaboration is to lend our resources and experience in developing a quality custom antibody, while the researcher lends their expertise in antigen design and/or specific screening. Ultimately, a fair and mutually beneficial licensing agreement would be established.
Researchers would communicate with MBS throughout the development process, maintaining control over the testing and validation of the antibody. MBS will use our network of contacts in the biotechnology and diagnostic industries to market and sell the antibody, generating revenue for your research institution.
The identification of genetic biomarkers and pathways has revolutionized the process of drug discovery and created a flurry of novel therapeutic targets and methods. In today’s regulatory environment, it is critical to have high quality assay reagents to provide proof of concept, and more importantly, the ability to track the effectiveness of a therapy through clinical trials and beyond. MBS has partnered with top pharmaceutical companies, using 19 years of antibody development experience and proprietary protocols, to provide the best possible antibodies to monitor their therapeutic applications.
Please contact us at sales@mainebiotechnology.com to discuss the opportunity for partnership in antibody development.